Arimori T, Ikemura N, Okamoto T, Takagi J, Standley DM, Hoshino A (2022) Engineering ACE2 decoy receptors to combat viral escapability. Trends Pharmacol Sci 43(10):838–851

CAS  PubMed  PubMed Central  Google Scholar 

Bouhanick B, Delchier MC, Lagarde S, Boulestreau R, Conil C, Gosse P et al (2021) Radiofrequency ablation for adenoma in patients with primary aldosteronism and hypertension: ADERADHTA, a pilot study. J Hypertens 39(4):759–765

CAS  PubMed  Google Scholar 

Buffolo F, Pieroni J, Ponzetto F, Forestiero V, Rossato D, Fonio P et al (2023) Prevalence of cortisol cosecretion in patients with primary aldosteronism: role of metanephrine in adrenal vein sampling. J Clin Endocrinol Metab 108(9):e720–e725

PubMed  Google Scholar 

Costa N, Mounie M, Gombault-Datzenko E, Boulestreau R, Cremer A, Delchier MC et al (2023) Cost analysis of radiofrequency ablation for adrenal adenoma in patients with primary aldosteronism and hypertension: results from the ADERADHTA pilot study and comparison with surgical adrenalectomy. Cardiovasc Intervent Radiol 46(1):89–97

PubMed  Google Scholar 

Deutschbein T, Reimondo G, Di Dalmazi G, Bancos I, Patrova J, Vassiliadi DA et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499–508

CAS  PubMed  PubMed Central  Google Scholar 

Eiring P, Klein T, Backes S, Streit M, Jungblut M, Doose S et al (2023) Coronaviruses use ACE2 monomers as Entry-Receptors. Angew Chem Int Ed Engl 62(30):e202300821

CAS  PubMed  Google Scholar 

Erbay G, Pehlivan UA, Karadeli E (2022) A rare triplet found in a patient with Drug-Resistant hypertension: Adnexal-Adrenal sex Cord-Stromal tumors and Castleman’s disease. Cureus 14(8):e28220

PubMed  PubMed Central  Google Scholar 

Fassnacht M, Tsagarakis S, Terzolo M (2023) European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 189(1):G1–g42

PubMed  Google Scholar 

Hamidi O (2021) Cardiovascular and metabolic consequences in patients with asymptomatic adrenal adenomas. Curr Opin Endocrinol Diabetes Obes 28(3):277–282

CAS  PubMed  Google Scholar 

Jansen PM, Stowasser M (2022) Aldosterone-producing adenoma associated with non-suppressed Renin: a case series. J Hum Hypertens 36(4):373–380

CAS  PubMed  Google Scholar 

Kaur R, Young S (2023) Discordant imaging: adrenal vein sampling in almost half of patients with primary aldosteronism and a unilateral adrenal adenoma. Intern Med J 53(8):1409–1414

CAS  PubMed  Google Scholar 

Lallawmzuali C, Khan AA, Ahuja S, Zaheer S (2023) Synchronous ipsilateral adrenal cortical adenoma and ganglioneuroma: A case report. Indian J Urol 39(4):322–324

PubMed  PubMed Central  Google Scholar 

Mulè G, Geraci G (2021) Haemodynamics of primary aldosteronism associated with adrenocortical adenoma: insights from bioimpedance cardiography measurements. J Intern Med 289(1):134–136

PubMed  Google Scholar 

Ohara N, Kobayashi M, Yoneoka Y, Hasegawa G, Aoki Y, Nakamura Y et al (2022) Primary aldosteronism presenting with hypertension five days after delivery: A case report and literature review. Intern Med 61(4):507–512

PubMed  Google Scholar 

Pelsma ICM, Fassnacht M (2023) Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol 189(4):S88–s101

PubMed  Google Scholar 

Pitsava G, Faucz FR (2022) Update on the genetics of primary aldosteronism and Aldosterone-Producing adenomas. Curr Cardiol Rep 24(9):1189–1195

PubMed  PubMed Central  Google Scholar 

Rahimi L, Kittithaworn A (2024) Kidney function in patients with adrenal adenomas: A Single-Center retrospective cohort study. J Clin Endocrinol Metab 109(9):e1750–e1758

PubMed  Google Scholar 

Rege J, Bandulik S, Nanba K (2023) Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism. Nat Genet 55(10):1623–1631

CAS  PubMed  Google Scholar 

Su C, Li C, Hu X, Wang J, Liu L, Zhang X et al (2024) Association between ACE2 and lung diseases. Infect Drug Resist 17:1771–1780

PubMed  PubMed Central  Google Scholar 

Sun F, Liu X, Zhang H, Zhou X, Zhao Z, He H et al (2023) Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. Hypertens Res 46(1):91–99

PubMed  Google Scholar 

Sun J, Dong Y, Wang H, Guo X, Suo N, Li S et al (2024) The improvement of postoperative blood pressure and associated factors in patients with hormone-negative adrenal adenoma and hypertension. J Surg Oncol 129(6):1073–1081

CAS  PubMed  Google Scholar 

Watanabe D, Morimoto S (2024) Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics. Heart Vessels 39(1):65–74

PubMed  Google Scholar 

Wu X, Azizan EAB (2023) Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. Nat Genet 55(6):1009–1021

CAS  PubMed  PubMed Central  Google Scholar 

Zhang CD, Li D, Kaur RJ, Ebbehoj A (2021) Cardiometabolic outcomes and mortality in patients with adrenal adenomas in a Population-based setting. J Clin Endocrinol Metab 106(11):3320–3330

PubMed  PubMed Central  Google Scholar 

Zhu Y, Zhang S, Wang Z, Wang Z, Zhu S (2023) ACE2 receptor: A potential Pharmacological target in COVID-19. Curr Protein Pept Sci 24(9):701–710

CAS  PubMed  Google Scholar